PACE Clinical helps sponsors predict adherence, personalize support, and proactively manage adherence risk, improving retention, strengthening data integrity, and accelerating time to market.

Transforming Adherence from Risk to Performance

image-gen 

Adherence Risk Management (ARM)

Adherence Risk Management (ARM) is a behavior-driven SaaS platform designed to proactively manage patient adherence in clinical trials.

Rather than reacting to drop-out and protocol deviations after they occur, ARM introduces predictive, measurable adherence risk management across the full patient journey.

For sponsors and clinical teams, this means:

  • Earlier identification of adherence risk
  • Targeted, personalized patient support
  • Improved adherence and data reliability
  • Reduced operational burden at site level

ARM enables adherence to be managed as a controllable trial performance variable — not an unpredictable patient behavior.

The Strategic Problem ARM Solves

Despite years of patient-centric initiatives and digital engagement tools, early drop-out rates in clinical trials remain consistently high.

Why?

Because most solutions focus on communication, not behavioral risk prediction.

Adherence is dynamic.
It evolves with patient experience, treatment burden, and emotional state.
Generic reminders and static content cannot address this complexity.

ARM introduces a different paradigm:

1dd4bb5c-30ea-4739-84ee-f76ed74505be-2026-04-09 



beamer
eu
imi
efpia